Dimension Therapeutics, Inc. Deferred Revenue
Dimension Therapeutics, Inc. had Deferred Revenue of $10.48 million as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2017-11-06
- 2017-09-30: Deferred Revenue, Current $10.48M.
- 2017-06-30: Deferred Revenue, Current $9.87M.
- 2017-03-31: Deferred Revenue, Current $9.18M.
- 2016-12-31: Deferred Revenue, Current $8.66M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-09-30 | $10.48M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $9.87M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $9.18M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $8.66M 10-Q · filed 2017-11-06 |
| 2016-09-30 | $7.80M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $7.41M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $7.11M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $6.83M 10-K · filed 2017-03-09 |
| 2015-09-30 | $6.33M 10-Q · filed 2015-12-04 |
| 2014-12-31 | $5.13M 10-K · filed 2016-03-24 |